Jefferies Maintains Buy on Novartis, Raises Price Target to $122.5
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Peter Welford maintains a Buy rating on Novartis (NYSE:NVS) and raises the price target from $121 to $122.5.
July 02, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Peter Welford maintains a Buy rating on Novartis and raises the price target from $121 to $122.5.
The raised price target and maintained Buy rating from a reputable analyst at Jefferies is likely to positively impact investor sentiment and could lead to a short-term increase in the stock price of Novartis.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100